CPIX Earnings & Financial Statements
Cumberland Pharmaceuticals Inc.
$7.75
+$0.26(+3.47%)
49
Overall
60
Value
30
Tech
57
Quality
Market Cap
$112.22M
Volume
7.99K
52W Range
$1.85 - $9.28
Target Price
$8.50
CPIX earnings and financial statements: Cumberland Pharmaceuticals Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
CPIX Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $44.52M | $37.87M | $39.55M | $42.01M | $35.99M |
| Cost of revenue | $6.67M | $6.59M | $6.07M | $9.12M | $8.81M |
| Operating income | -$2.79M | -$6.43M | -$9.55M | -$5.70M | -$7.68M |
| EBITDA | $2.98M | $210.7K | $168.8K | $332.9K | -$857.8K |
| Net income | -$2.84M | -$6.48M | -$6.28M | -$5.57M | -$3.51M |
| EPS (diluted) | $-0.19 | $-0.46 | $-0.44 | $-0.76 | $-0.48 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $76.82M | $75.58M | $81.78M | $92.93M | $84.46M |
| Total liabilities | $52.28M | $53.04M | $52.52M | $56.95M | $41.86M |
| Shareholders’ equity | $24.88M | $22.85M | $29.60M | $36.27M | $42.81M |
| Cash and equivalents | $11.44M | $17.96M | $18.32M | $19.76M | $27.04M |
| Long-term debt | $9.71M | $15.12M | $18.08M | $20.79M | $15.09M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | $4.93M | -$612.2K | $6.09M | $8.45M | $6.34M |
| Capital expenditure | -$182.3K | -$179.7K | -$453.1K | -$2.07M | -$354.5K |
| Free cash flow | $4.75M | -$791.9K | $5.64M | $6.38M | $5.99M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CPIX | $7.75 | +3.5% | 7.99K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cumberland Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW